• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·Belgium·Basic Materials·ENGB.BR
Share

Rosier S.A. Stocks

€ 0Last Updated 23.03.2026

Issuer Rating

1/7
Performance

Poor

Risk

High

Recommendation

Sell

Market Cap

€ 68.86M

€ 0
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Greatly overvalued vs peers

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Rosier SA produces and markets mineral fertilizers in Belgium and the Netherlands. It offers granular, water-soluble, and liquid fertilizers. The company was formerly known as S.A. Engrais Rosier and changed its name to Rosier SA in 2001. Rosier SA was founded in 1880 and is based in Frasnes-lez-Anvaing, Belgium. Rosier S.A. is a subsidiary of Borealis AG.

Company Valuation

Greatly overvalued
1/7

From both historical and forecast perspectives, the stock is considerably overpriced compared to similar stocks. In particular, the stock is overpriced on P/E, 'expensive

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.05.2026 15:00

Anthropic will pay nearly $45 billion for access to SpaceX supercomputers

21.05.2026 14:35

The Ebola outbreak has sent shares of biotech GeoVax skyrocketing. It's developing a vaccine

21.05.2026 14:12

Wedbush analyst predicted a Tesla and SpaceX merger in 2027

21.05.2026 12:20

SpaceX IPO will make Elon Musk the world's first and only trillionaire

21.05.2026 11:25

WHO reports hantavirus and a dangerous Ebola outbreak. Will this set off a new vaccine race?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn
  • X (Twitter)
  • LinkedIn
Oninvest© 2026